69 results
8-K
EX-10.1
ONCT
Oncternal Therapeutics Inc
21 Jul 20
Oncternal Therapeutics Announces $6.2 Million Registered Direct Offering
4:06pm
or packaging of, the testing of, the sale of, or the labeling and promotion of any Pharmaceutical Product, (ii) withdraws its approval of, requests
8-K
EX-10.1
fi98yhr
21 May 20
Oncternal Therapeutics Announces $5.0 Million Registered Direct Offering
4:31pm
424B3
ia53vezblxmpsmb3uzz0
8 May 19
Prospectus supplement
12:00am
S-4/A
j85uo19u3qup6c7 38
3 May 19
Registration of securities issued in business combination transactions (amended)
9:51pm
S-4
EX-10.54
tp53sbk4af6hp5
5 Apr 19
Registration of securities issued in business combination transactions
9:02pm
S-4
c89e5bsi5pcz
5 Apr 19
Registration of securities issued in business combination transactions
9:02pm
8-K
EX-2.1
lw90y 5pq
3 Oct 12
Entry into a Material Definitive Agreement
12:00am